- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Nuclear Medicine/Radiopharmaceutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Nuclear Medicine/Radiopharmaceutic market size is estimated to be worth US$ 5062.8 million in 2021 and is forecast to a readjusted size of USD 8421.9 million by 2028 with a CAGR of 7.5% during review period. Diagnostic accounting for % of the Nuclear Medicine/Radiopharmaceutic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tc-99 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nuclear Medicine/Radiopharmaceutic include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nuclear Medicine/Radiopharmaceutic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Market segment by Application can be divided into
Diagnostic
Therapeutic
The key market players for global Nuclear Medicine/Radiopharmaceutic market are listed below:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine/Radiopharmaceutic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceutic, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceutic from 2019 to 2022.
Chapter 3, the Nuclear Medicine/Radiopharmaceutic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine/Radiopharmaceutic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nuclear Medicine/Radiopharmaceutic market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nuclear Medicine/Radiopharmaceutic.
Chapter 13, 14, and 15, to describe Nuclear Medicine/Radiopharmaceutic sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Nuclear Medicine/Radiopharmaceutic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine/Radiopharmaceutic Market Size & Forecast
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Sales in Volume (2017-2028)
1.4.3 Global Nuclear Medicine/Radiopharmaceutic Price (2017-2028)
1.5 Global Nuclear Medicine/Radiopharmaceutic Production Capacity Analysis
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Total Production Capacity (2017-2028)
1.5.2 Global Nuclear Medicine/Radiopharmaceutic Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nuclear Medicine/Radiopharmaceutic Market Drivers
1.6.2 Nuclear Medicine/Radiopharmaceutic Market Restraints
1.6.3 Nuclear Medicine/Radiopharmaceutic Trends Analysis
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product and Services
2.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bracco Imaging
2.2.1 Bracco Imaging Details
2.2.2 Bracco Imaging Major Business
2.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
2.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product and Services
2.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lantheus Medical Imaging
2.4.1 Lantheus Medical Imaging Details
2.4.2 Lantheus Medical Imaging Major Business
2.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
2.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Product and Services
2.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jubilant Pharma
2.6.1 Jubilant Pharma Details
2.6.2 Jubilant Pharma Major Business
2.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product and Services
2.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Product and Services
2.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product and Services
2.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 SIEMENS
2.9.1 SIEMENS Details
2.9.2 SIEMENS Major Business
2.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Product and Services
2.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 China Isotope & Radiation
2.10.1 China Isotope & Radiation Details
2.10.2 China Isotope & Radiation Major Business
2.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product and Services
2.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Yantai Dongcheng Biochemicals
2.11.1 Yantai Dongcheng Biochemicals Details
2.11.2 Yantai Dongcheng Biochemicals Major Business
2.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product and Services
2.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nuclear Medicine/Radiopharmaceutic Breakdown Data by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceutic Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nuclear Medicine/Radiopharmaceutic
3.4 Market Concentration Rate
3.4.1 Top 3 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2021
3.4.2 Top 6 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2021
3.5 Global Nuclear Medicine/Radiopharmaceutic Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nuclear Medicine/Radiopharmaceutic Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Region
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales in Volume by Region (2017-2028)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2028)
4.2 North America Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028)
4.3 Europe Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028)
4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028)
4.5 South America Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028)
4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nuclear Medicine/Radiopharmaceutic Sales in Volume by Type (2017-2028)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2028)
5.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nuclear Medicine/Radiopharmaceutic Sales in Volume by Application (2017-2028)
6.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2017-2028)
6.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2028)
7.2 North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2028)
7.3 North America Nuclear Medicine/Radiopharmaceutic Market Size by Country
7.3.1 North America Nuclear Medicine/Radiopharmaceutic Sales in Volume by Country (2017-2028)
7.3.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2028)
8.2 Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2028)
8.3 Europe Nuclear Medicine/Radiopharmaceutic Market Size by Country
8.3.1 Europe Nuclear Medicine/Radiopharmaceutic Sales in Volume by Country (2017-2028)
8.3.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2028)
9.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2028)
9.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2028)
10.2 South America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2028)
10.3 South America Nuclear Medicine/Radiopharmaceutic Market Size by Country
10.3.1 South America Nuclear Medicine/Radiopharmaceutic Sales in Volume by Country (2017-2028)
10.3.2 South America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2028)
11.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2028)
11.3 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nuclear Medicine/Radiopharmaceutic and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nuclear Medicine/Radiopharmaceutic
12.3 Nuclear Medicine/Radiopharmaceutic Production Process
12.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nuclear Medicine/Radiopharmaceutic Typical Distributors
13.3 Nuclear Medicine/Radiopharmaceutic Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nuclear Medicine/Radiopharmaceutic Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product and Services
Table 6. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 8. Bracco Imaging Major Business
Table 9. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
Table 10. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product and Services
Table 14. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 16. Lantheus Medical Imaging Major Business
Table 17. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
Table 18. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Nuclear Medicine/Radiopharmaceutic Product and Services
Table 22. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Jubilant Pharma Major Business
Table 25. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product and Services
Table 26. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Nordion Basic Information, Manufacturing Base and Competitors
Table 28. Nordion Major Business
Table 29. Nordion Nuclear Medicine/Radiopharmaceutic Product and Services
Table 30. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Major Business
Table 33. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product and Services
Table 34. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 36. SIEMENS Major Business
Table 37. SIEMENS Nuclear Medicine/Radiopharmaceutic Product and Services
Table 38. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 40. China Isotope & Radiation Major Business
Table 41. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product and Services
Table 42. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Yantai Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
Table 44. Yantai Dongcheng Biochemicals Major Business
Table 45. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product and Services
Table 46. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 48. Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Nuclear Medicine/Radiopharmaceutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Nuclear Medicine/Radiopharmaceutic Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 51. Head Office and Nuclear Medicine/Radiopharmaceutic Production Site of Key Manufacturer
Table 52. Nuclear Medicine/Radiopharmaceutic New Entrant and Capacity Expansion Plans
Table 53. Nuclear Medicine/Radiopharmaceutic Mergers & Acquisitions in the Past Five Years
Table 54. Global Nuclear Medicine/Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)
Table 55. Global Nuclear Medicine/Radiopharmaceutic Sales by Region (2023-2028) & (Kiloton)
Table 56. Global Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Nuclear Medicine/Radiopharmaceutic Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 59. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 60. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Nuclear Medicine/Radiopharmaceutic Price by Type (2017-2022) & (US$/Ton)
Table 63. Global Nuclear Medicine/Radiopharmaceutic Price by Type (2023-2028) & (US$/Ton)
Table 64. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 65. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 66. Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Nuclear Medicine/Radiopharmaceutic Price by Application (2017-2022) & (US$/Ton)
Table 69. Global Nuclear Medicine/Radiopharmaceutic Price by Application (2023-2028) & (US$/Ton)
Table 70. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 71. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 72. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 75. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 76. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 77. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 78. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 79. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 80. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 83. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 84. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 85. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 86. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)
Table 87. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2023-2028) & (Kiloton)
Table 88. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 91. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 92. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 93. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 94. South America Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 95. South America Nuclear Medicine/Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 96. South America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 99. South America Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 100. South America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 101. South America Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 102. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)
Table 103. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Region (2023-2028) & (Kiloton)
Table 104. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 107. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 108. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 109. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 110. Nuclear Medicine/Radiopharmaceutic Raw Material
Table 111. Key Manufacturers of Nuclear Medicine/Radiopharmaceutic Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Nuclear Medicine/Radiopharmaceutic Typical Distributors
Table 115. Nuclear Medicine/Radiopharmaceutic Typical Customers
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2021
Figure 3. Tc-99
Figure 4. I-123/131
Figure 5. In-111
Figure 6. Xe-133
Figure 7. Th-201
Figure 8. Ga-67
Figure 9. Other
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application in 2021
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Global Nuclear Medicine/Radiopharmaceutic Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Sales (2017-2028) & (Kiloton)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Price (2017-2028) & (US$/Ton)
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Production Capacity (2017-2028) & (Kiloton)
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Nuclear Medicine/Radiopharmaceutic Market Drivers
Figure 20. Nuclear Medicine/Radiopharmaceutic Market Restraints
Figure 21. Nuclear Medicine/Radiopharmaceutic Market Trends
Figure 22. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturer in 2021
Figure 23. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Figure 24. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2028)
Figure 28. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2017-2028)
Figure 29. North America Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028) & (USD Million)
Figure 30. Europe Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028) & (USD Million)
Figure 32. South America Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue (2017-2028) & (USD Million)
Figure 34. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2028)
Figure 35. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2017-2028)
Figure 36. Global Nuclear Medicine/Radiopharmaceutic Price by Type (2017-2028) & (US$/Ton)
Figure 37. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 38. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2017-2028)
Figure 39. Global Nuclear Medicine/Radiopharmaceutic Price by Application (2017-2028) & (US$/Ton)
Figure 40. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2028)
Figure 41. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 42. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2028)
Figure 43. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2028)
Figure 44. United States Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2028)
Figure 48. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 49. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2028)
Figure 50. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2028)
Figure 51. Germany Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2017-2028)
Figure 60. China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2028)
Figure 67. South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 68. South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2028)
Figure 69. South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Nuclear Medicine/Radiopharmaceutic in 2021
Figure 81. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure 82. Nuclear Medicine/Radiopharmaceutic Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
